| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |